A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CB / clenbuterol

[Related PubMed/MEDLINE]
Total Number of Papers: 36
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CB  (>> Co-occurring Abbreviation)
Long Form:   clenbuterol
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 In situ synthesis of graphene oxide/gold nanocomposites as ultrasensitive surface-enhanced Raman scattering substrates for clenbuterol detection. LOD, SERS
2019 Role of beta-adrenergic signaling in masseter muscle. beta-AR, DOB, mTOR
2016 Role of phosphodiesterase 4 expression in the Epac1 signaling-dependent skeletal muscle hypertrophic action of clenbuterol. AR, CaMKII, cAMP, HDAC4, PDE4, SOL, TA, TL, WT
2015 Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition. FOXO, IGF1, MHC, mTOR
2014 Temporal changes in ERK phosphorylation are harmonious with 4E-BP1, but not p70S6K, during clenbuterol-induced hypertrophy in the rat gastrocnemius. eEF2, ERK, mTORC1
2013 Role of masseter muscle beta₂-adrenergic signaling in regulation of muscle activity, myosin heavy chain transition, and hypertrophy. MHC, SB
2011 Clenbuterol suppresses proteasomal and lysosomal proteolysis and atrophy-related genes in denervated rat soleus muscles independently of Akt. DEN, Ub
2009 Effects of combined stretching and clenbuterol on disuse atrophy in rat soleus muscle. CON, HU, SOL, ST
2008 Dispersive liquid-liquid microextraction combined with semi-automated in-syringe back extraction as a new approach for the sample preparation of ionizable organic compounds prior to liquid chromatography. DLLME, FA, LC
10  2007 The effect of long-term exposure to combinations of growth promoters in Long Evans rats: part 1: Endocrine adrenal function. DEX
11  2007 The effect of long-term exposure to combinations of growth promoters in Long Evans rats: part 2. Adrenal morphology (histopathology and immunochemical studies). DEX
12  2007 Three-phase solvent bar microextraction and determination of trace amounts of clenbuterol in human urine by liquid chromatography and electrospray tandem mass spectrometry. ES-TMS, LC, TPSBME
13  2006 Effects of clenbuterol and cyclosporin A on the myosin heavy chain mRNA level and the muscle mass in rat masseter. CaN, CsA
14  2006 The anti-inflammatory effects of IV administered clenbuterol in horses with recurrent airway obstruction. AF, HDS, LPS, RAO, TCC
15  2006 The effect of aerosolized and intravenously administered clenbuterol and aerosolized fluticasone propionate on horses challenged with Aspergillus fumigatus antigen. Af, FP, IL, RAO
16  2005 Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway. HU, IGF-I
17  2005 Effects of intermittent weight-bearing and clenbuterol on disuse atrophy of rat hindlimb muscles. CON, EDL, HU, IWB, SOL
18  2004 Enhancement of hybrid-fiber types in rat soleus muscle after clenbuterol administration during hindlimb unloading. HU
19  2004 Fish oil supplementation in F1 generation associated with naproxen, clenbuterol, and insulin administration reduce tumor growth and cachexia in Walker 256 tumor-bearing rats. ---
20  2004 Hybrid fibres under slow-to-fast transformations: expression is of myosin heavy and light chains in rat soleus muscle. HU, MHC, MLC
21  2003 Changes in muscle proteins and spermidine content in response to unloading and clenbuterol treatment. EDL
22  2002 Alteration of contractile force and mass in the senescent diaphragm with beta(2)-agonist treatment. MHC
23  2002 Distribution and muscle-sparing effects of clenbuterol in hindlimb-suspended rats. ---
24  2002 Muscle-specific effects of hindlimb suspension and clenbuterol in mature male rats. ADL, EDL, HLS, Plan, SOL
25  2001 Attenuation of insulin resistance by chronic beta2-adrenergic agonist treatment possible muscle specific contributions. CT, FG, FO, SO, TB
26  2000 Effects of unweighting and clenbuterol on myosin light and heavy chains in fast and slow muscles of rat. EDL, GAS, HU, SOL
27  1999 Clenbuterol plasma pharmacokinetics in cattle. ---
28  1997 Effect of clenbuterol on growth, carcase and skeletal muscle characteristics in broiler chickens. EHL, GAS
29  1996 Interaction between clenbuterol and run training: effects on exercise performance and MLC isoform content. CON, EX, MLC
30  1994 Effects of beta 2-stimulants on contractility and fatigue of canine urethral sphincter. IUP, TB
31  1994 [The effect of the beta-adrenergic agonist clenbuterol on the growth of skeletal muscles of rats]. EDL
32  1993 The affinity of ractopamine, clenbuterol, and L-644,969 for the beta-adrenergic receptor population in porcine adipose tissue and skeletal muscle membrane. LM, RA, ST
33  1989 Acute effects of beta-adrenergic agonists on porcine adipocyte metabolism in vitro. ADA, EPI, RAC, THEO
34  1989 Clenbuterol-induced desensitization in murine adipocytes: relationship to in vivo effectiveness. EPI
35  1989 Influence of the beta 2-adrenergic agonist clenbuterol on insulin-stimulated lipogenesis in mouse adipocytes. EPI
36  1989 Skeletal muscle protein synthesis and growth hormone secretion in young lambs treated with clenbuterol. BR, FC, FSR, GH, ST